915145-05-0 Usage
General Description
2,4-Dichloro-3-fluorobenzoic acid is a chemical compound with the molecular formula C7H3Cl2FO2. It is a derivative of benzoic acid and is classified as a chlorinated aromatic compound. This chemical is commonly used as a herbicide to control broadleaf weeds in crops such as soybeans, peanuts, and wheat. It works by disrupting the growth of weeds and interfering with their ability to produce essential proteins. 2,4-Dichloro-3-fluorobenzoic acid is considered to have low acute toxicity in mammals, but prolonged exposure can be harmful. It is important to handle and use this chemical with proper safety precautions to minimize the risk of harm to humans and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 915145-05-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,5,1,4 and 5 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 915145-05:
(8*9)+(7*1)+(6*5)+(5*1)+(4*4)+(3*5)+(2*0)+(1*5)=150
150 % 10 = 0
So 915145-05-0 is a valid CAS Registry Number.
915145-05-0Relevant articles and documents
5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
-
Page/Page column 78, (2010/11/17)
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof wherein A is hydrogen, C1-4alkyl, C3-6cycloalkyl, C1-3alkoxy, C1-3alkoxy C1-4alkyl, C1-2fluoroalkyl, halogen, NR6 R7, optionally substituted heteroaryl (Het), or optionally substituted phenyl, and R1, R2, R3, R4, R5, R6 and R7 are as defined in the description. The compounds or salts are thought to modulate P2X7 receptor function and to be capable of antagonizing the effects of ATP at the P2X7 receptor. The invention also provides the use of the compound or salt in the treatment or prophylaxis of, for example, inflammatory pain, neuropathic pain, visceral pain, rheumatoid arthritis, osteoarthritis or neurodegenerative disorders.